Pharmafile Logo
Pharmafocus logo
Advanced Search
fda_23

FDA approves Roche’s Enspryng for neuromyelitis optica

August 17, 2020
Sales and Marketing COVID, COVID-19, coronavirus

The FDA has granted approval for Roche’s Enspryng for treating the central nervous system disorder neuromyelitis optica. The drug (satralizumab) …

News
fda2outsideweb

FDA panel votes 9-1 in favour of approval for Mesoblast’s Ryoncil in paediatric steroid-refractory acute graft versus host disease

August 14, 2020
Medical Communications, Sales and Marketing FDA, Mesoblast, Ryoncil, pharma

It’s good news for Mesoblast as an expert FDA panel gave a glowing recommendation for the approval in the US …

News
fillip

Philippines expected to approve Russia’s ‘Sputnik’ COVID-19 vaccine

August 14, 2020
Medical Communications COVID, COVID-19, coronavirus, vaccines

The Philippines is expected to begin large scale human testing of Russia’s controversial ‘Sputnik’ coronavirus vaccine. Rodrigo Duterte, the President …

News
shutterstock_244903099

Novavax and Janssen commit 90 million COVID-19 vaccine doses to UK Government with two new deals

August 14, 2020
Manufacturing and Production, Medical Communications, Sales and Marketing COVID-19, J&J, JJ, Novavax, UK, pharma

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …

News
vxxxxeer_0

Top Russian doctor quits over questionable ethics that rushed through coronavirus vaccine approval

August 14, 2020
Medical Communications

Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 14, 2020
Medical Communications COVID-19, coronavirus, pandemic

The top 10 news stories this week once again focus on coronavirus treatments and vaccines, as President Putin announced that …

News
truvada-web

Gilead’s Truvada becomes first China-approved drug to prevent HIV-1

August 13, 2020
Sales and Marketing China, Truvada, approval. HIV

China’s National Medical Products Administration (NMPA) has awarded approval to Gilead’s Truvada in a pre-exposure prophylaxis (PrEP) indication to prevent …

News

MHRA designates cenobamate as a Promising Innovative Medicine for treating drug resistant seizures

August 13, 2020
Research and Development MHRA, cenobamate, seizures

Arvelle Therapeutics has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has given their anti-seizure medication (cenobamate) …

News
800px-thumbnail

COVID-19 patients are experiencing long-term effects from the virus

August 13, 2020
COVID, COVID-19, coronavirus

Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study.

News

FDA approves NS Pharma’s Viltepso for Duchenne muscular dystrophy, but concerns over benefit persist

August 13, 2020
Sales and Marketing Duchenne Muscular Dystrophy, FDA, NS pharma, Viltepso

NS Pharma has claimed a tentative FDA approval for its Viltepso (viltolarsen) injection in the treatment of Duchenne muscular dystrophy …

News
fake_news

Coronavirus fake news has led to hundreds of deaths, according to a new study

August 13, 2020
Medical Communications COVID, coronavirus, fake news

At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according …

News
shutterstock_158366573

Racial minority groups are not adequately represented in COVID-19 clinical studies, research argues

August 12, 2020
Research and Development COVID-19, Gilead, pharma, remdesivir

New research has warned that minority groups and people of colour are underrepresented in current trials for COVID-19 therapies, despite …

News
bristol_myers_squibb

Bristol Myers Squibb announces positive results from Opdivo clinical trials

August 12, 2020
Research and Development Bristol-Myers Squibb, Cancer, bristol myers squibb

Bristol Myers Squibb has announced positive data from two Phase 3 clinical trials of its drug Opdivo. The first trial …

News
giant-mexican-flag-waves

Mexico to hold trials for Chinese and American COVID-19 vaccines

August 12, 2020
Research and Development COVID-19, Mexico, Mexico coronavirus

Mexico aims to conduct late stage trials for coronavirus vaccines designed by US and Chinese companies. This is in hope …

News
moderna

Moderna commits 100 million COVID-19 vaccine doses to the US

August 12, 2020
Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, US, Vaccine, pharma

Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to …

News
covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

August 12, 2020
Research and Development COVID-19, coronavirus, covid news

The coronavirus news this week once again focuses on vaccines, as AstraZeneca signed its first deal in China to produce …

News
shutterstock_273326141

Bayer scoops up women’s healthcare biotech KaNDy Therapeutics in potential $1bn+ deal

August 11, 2020
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, KaNDy Therapeutics, menopause, pharma

Bayer is set to acquire UK-based biotech KaNDy Therapeutics, assimilating the firm’s women’s healthcare development portfolio in a newly announced …

News
roche

Roche’s entrolizumab disappoints at Phase 3 in moderately to severely active ulcerative colitis

August 11, 2020
Manufacturing and Production, Research and Development Roche, etrolizumab, trial failure, ulcerative colitis

Roche has voiced its disappointment after its investigational therapy etrolizumab showed “mixed results” as a treatment for moderately to severely …

News
fda

Gilead applies for FDA approval to treat coronavirus patients with remdesivir

August 11, 2020
Manufacturing and Production COVID-19, Gilead, coronavirus

Gilead Sciences has asked the FDA to approve its drug remdesivir to treat COVID-19 patients. The drug would go under …

News
gestational_diabetes_kit

Arthritis drug Abatacept could be used to treat type 1 diabetes

August 11, 2020
Manufacturing and Production diabetes, insulin, tye 1, type 2

People with type 1 diabetes could see their lives extended by the arthritis drug Abatacept, new study finds. Researchers at …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026